Annual Net Income:
-$69.92M+$2.93M(+4.02%)Summary
- As of today, ABUS annual net profit is -$69.92 million, with the most recent change of +$2.93 million (+4.02%) on December 31, 2024.
- During the last 3 years, ABUS annual net income has risen by +$6.33 million (+8.30%).
- ABUS annual net income is now -334.60% below its all-time high of $29.80 million, reached on December 31, 2012.
Performance
ABUS Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Net Income:
-$7.74M-$10.27M(-406.86%)Summary
- As of today, ABUS quarterly net profit is -$7.74 million, with the most recent change of -$10.27 million (-406.86%) on September 30, 2025.
- Over the past year, ABUS quarterly net income has increased by +$11.97 million (+60.73%).
- ABUS quarterly net income is now -120.03% below its all-time high of $38.65 million, reached on December 31, 2012.
Performance
ABUS Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Net Income:
-$42.28M+$11.97M(+22.07%)Summary
- As of today, ABUS TTM net profit is -$42.28 million, with the most recent change of +$11.97 million (+22.07%) on September 30, 2025.
- Over the past year, ABUS TTM net income has increased by +$34.42 million (+44.88%).
- ABUS TTM net income is now -237.71% below its all-time high of $30.70 million, reached on March 31, 2013.
Performance
ABUS TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
ABUS Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +4.0% | +60.7% | +44.9% |
| 3Y3 Years | +8.3% | +55.9% | +38.6% |
| 5Y5 Years | +54.5% | +58.7% | +40.8% |
ABUS Net Income Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -0.7% | +8.3% | -406.9% | +68.4% | at high | +45.2% |
| 5Y | 5-Year | -9.7% | +54.5% | -406.9% | +68.4% | at high | +45.2% |
| All-Time | All-Time | -334.6% | +81.8% | -120.0% | +96.5% | -237.7% | +89.1% |
ABUS Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$7.74M(-406.9%) | -$42.28M(+22.1%) |
| Jun 2025 | - | $2.52M(+110.3%) | -$54.25M(+29.1%) |
| Mar 2025 | - | -$24.53M(-95.7%) | -$76.57M(-9.5%) |
| Dec 2024 | -$69.92M(+4.0%) | -$12.53M(+36.4%) | -$69.92M(+8.8%) |
| Sep 2024 | - | -$19.72M(+0.4%) | -$76.70M(+0.5%) |
| Jun 2024 | - | -$19.80M(-10.7%) | -$77.09M(-3.6%) |
| Mar 2024 | - | -$17.88M(+7.4%) | -$74.39M(-2.1%) |
| Dec 2023 | -$72.85M(-4.9%) | -$19.31M(+3.9%) | -$72.85M(+3.5%) |
| Sep 2023 | - | -$20.10M(-17.6%) | -$75.47M(-3.5%) |
| Jun 2023 | - | -$17.09M(-4.6%) | -$72.93M(-4.1%) |
| Mar 2023 | - | -$16.34M(+25.5%) | -$70.03M(-0.8%) |
| Dec 2022 | -$69.46M(+8.9%) | -$21.93M(-24.8%) | -$69.46M(-0.9%) |
| Sep 2022 | - | -$17.57M(-23.8%) | -$68.84M(+2.3%) |
| Jun 2022 | - | -$14.19M(+10.0%) | -$70.44M(+6.9%) |
| Mar 2022 | - | -$15.77M(+26.1%) | -$75.63M(+0.8%) |
| Dec 2021 | -$76.25M(-19.6%) | -$21.32M(-11.3%) | -$76.25M(-5.9%) |
| Sep 2021 | - | -$19.16M(+1.2%) | -$71.97M(-0.6%) |
| Jun 2021 | - | -$19.39M(-18.4%) | -$71.56M(-8.0%) |
| Mar 2021 | - | -$16.38M(+3.9%) | -$66.27M(-4.0%) |
| Dec 2020 | -$63.74M(+58.5%) | -$17.04M(+9.1%) | -$63.74M(+10.7%) |
| Sep 2020 | - | -$18.75M(-33.1%) | -$71.36M(+47.2%) |
| Jun 2020 | - | -$14.09M(-1.6%) | -$135.10M(+6.4%) |
| Mar 2020 | - | -$13.86M(+43.8%) | -$144.33M(+6.1%) |
| Dec 2019 | -$153.72M(-169.4%) | -$24.65M(+70.1%) | -$153.72M(-4.3%) |
| Sep 2019 | - | -$82.50M(-253.9%) | -$147.32M(-65.0%) |
| Jun 2019 | - | -$23.32M(-0.3%) | -$89.29M(-42.0%) |
| Mar 2019 | - | -$23.25M(-27.4%) | -$62.88M(-10.2%) |
| Dec 2018 | -$57.06M(+32.4%) | -$18.25M(+25.4%) | -$57.06M(+23.7%) |
| Sep 2018 | - | -$24.47M(-891.8%) | -$74.74M(-20.8%) |
| Jun 2018 | - | $3.09M(+117.7%) | -$61.87M(+25.7%) |
| Mar 2018 | - | -$17.43M(+51.5%) | -$83.22M(+1.4%) |
| Dec 2017 | -$84.41M(+78.0%) | -$35.93M(-209.8%) | -$84.41M(+68.4%) |
| Sep 2017 | - | -$11.60M(+36.5%) | -$267.18M(+2.9%) |
| Jun 2017 | - | -$18.25M(+2.0%) | -$275.17M(+28.9%) |
| Mar 2017 | - | -$18.63M(+91.5%) | -$386.92M(-0.7%) |
| Dec 2016 | -$384.16M(-528.5%) | -$218.69M(-1016.1%) | -$384.16M(-125.0%) |
| Sep 2016 | - | -$19.59M(+84.9%) | -$170.73M(+5.2%) |
| Jun 2016 | - | -$130.00M(-718.9%) | -$180.12M(-177.1%) |
| Mar 2016 | - | -$15.87M(-201.6%) | -$65.01M(-6.4%) |
| Dec 2015 | -$61.12M(-57.4%) | -$5.26M(+81.8%) | -$61.12M(+1.5%) |
| Sep 2015 | - | -$28.98M(-94.7%) | -$62.02M(-48.9%) |
| Jun 2015 | - | -$14.89M(-24.2%) | -$41.65M(-26.8%) |
| Mar 2015 | - | -$11.99M(-94.4%) | -$32.84M(+15.4%) |
| Dec 2014 | -$38.84M(-176.1%) | -$6.17M(+28.3%) | -$38.84M(-10.1%) |
| Sep 2014 | - | -$8.60M(-41.5%) | -$35.27M(-8.5%) |
| Jun 2014 | - | -$6.08M(+66.2%) | -$32.52M(-10.3%) |
| Mar 2014 | - | -$17.98M(-591.9%) | -$29.47M(-109.2%) |
| Dec 2013 | -$14.06M(-147.2%) | -$2.60M(+55.6%) | -$14.09M(-151.9%) |
| Sep 2013 | - | -$5.85M(-93.0%) | $27.17M(-8.1%) |
| Jun 2013 | - | -$3.03M(-16.7%) | $29.57M(-3.7%) |
| Mar 2013 | - | -$2.60M(-106.7%) | $30.70M(+1.8%) |
| Dec 2012 | $29.80M | $38.65M(+1220.2%) | $30.14M(+392.5%) |
| Sep 2012 | - | -$3.45M(-81.3%) | -$10.31M(-23.4%) |
| Jun 2012 | - | -$1.90M(+39.7%) | -$8.35M(+17.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$3.16M(-75.7%) | -$10.10M(-0.1%) |
| Dec 2011 | -$10.04M(+16.7%) | -$1.80M(-19.9%) | -$10.08M(-7.5%) |
| Sep 2011 | - | -$1.50M(+58.9%) | -$9.38M(+10.4%) |
| Jun 2011 | - | -$3.65M(-16.1%) | -$10.46M(+4.1%) |
| Mar 2011 | - | -$3.14M(-188.4%) | -$10.91M(+9.2%) |
| Dec 2010 | -$12.05M(-40.8%) | -$1.09M(+57.8%) | -$12.01M(+10.3%) |
| Sep 2010 | - | -$2.58M(+37.0%) | -$13.39M(-0.0%) |
| Jun 2010 | - | -$4.09M(+3.6%) | -$13.39M(-19.3%) |
| Mar 2010 | - | -$4.25M(-71.9%) | -$11.22M(-28.3%) |
| Dec 2009 | -$8.56M(+35.9%) | -$2.47M(+4.1%) | -$8.75M(-0.3%) |
| Sep 2009 | - | -$2.58M(-33.7%) | -$8.72M(+26.9%) |
| Jun 2009 | - | -$1.93M(-8.9%) | -$11.93M(+19.4%) |
| Mar 2009 | - | -$1.77M(+27.6%) | -$14.79M(-9.9%) |
| Dec 2008 | -$13.36M(-460.9%) | -$2.45M(+57.7%) | -$13.46M(-26.5%) |
| Sep 2008 | - | -$5.78M(-20.7%) | -$10.64M(-211.3%) |
| Jun 2008 | - | -$4.79M(-1009.9%) | -$3.42M(-3.4%) |
| Mar 2008 | - | -$431.90K(-217.1%) | -$3.30M(-45.9%) |
| Dec 2007 | -$2.38M(-112.8%) | $368.80K(-74.4%) | -$2.27M(+8.8%) |
| Sep 2007 | - | $1.44M(+130.7%) | -$2.48M(-256.1%) |
| Jun 2007 | - | -$4.68M(-870.7%) | -$697.50K(-103.0%) |
| Mar 2007 | - | $607.20K(+304.8%) | $22.88M(+21.1%) |
| Dec 2006 | $18.58M(+340.6%) | - | - |
| Dec 2006 | - | $150.00K(-95.3%) | $18.89M(+23.9%) |
| Sep 2006 | - | $3.23M(-82.9%) | $15.25M(+48.0%) |
| Jun 2006 | - | $18.89M(+658.9%) | $10.30M(+158.4%) |
| Mar 2006 | - | -$3.38M(+3.1%) | -$17.64M(-129.7%) |
| Dec 2005 | -$7.72M(+70.2%) | - | - |
| Dec 2005 | - | -$3.49M(-102.8%) | -$7.68M(-197.7%) |
| Sep 2005 | - | -$1.72M(+81.0%) | $7.86M(+40.4%) |
| Jun 2005 | - | -$9.05M(-237.6%) | $5.60M(-39.8%) |
| Mar 2005 | - | $6.58M(-45.4%) | $9.31M(+520.3%) |
| Dec 2004 | -$25.91M(+22.8%) | - | - |
| Dec 2004 | - | $12.06M(+402.8%) | -$2.22M(+90.6%) |
| Sep 2004 | - | -$3.98M(+25.5%) | -$23.66M(+13.2%) |
| Jun 2004 | - | -$5.35M(-8.2%) | -$27.27M(+8.5%) |
| Mar 2004 | - | -$4.94M(+47.3%) | -$29.79M(+4.0%) |
| Dec 2003 | -$33.55M(-1905.6%) | - | - |
| Dec 2003 | - | -$9.39M(-23.7%) | -$31.04M(-1.0%) |
| Sep 2003 | - | -$7.59M(+3.5%) | -$30.74M(-0.1%) |
| Jun 2003 | - | -$7.87M(-26.9%) | -$30.71M(-7.5%) |
| Mar 2003 | - | -$6.20M(+31.8%) | -$28.57M(-1.9%) |
| Dec 2002 | -$1.67M(+88.9%) | - | - |
| Dec 2002 | - | -$9.09M(-20.2%) | -$28.04M(-16.3%) |
| Sep 2002 | - | -$7.56M(-32.2%) | -$24.10M(-18.7%) |
| Jun 2002 | - | -$5.72M(-1.0%) | -$20.29M(-9.3%) |
| Mar 2002 | - | -$5.66M(-10.0%) | -$18.56M(-24.3%) |
| Dec 2001 | -$15.03M(-61.8%) | - | - |
| Dec 2001 | - | -$5.15M(-37.0%) | -$14.93M(-52.6%) |
| Sep 2001 | - | -$3.76M(+5.8%) | -$9.78M(-62.4%) |
| Jun 2001 | - | -$3.99M(-96.6%) | -$6.02M(-196.6%) |
| Mar 2001 | - | -$2.03M | -$2.03M |
| Dec 2000 | -$9.29M(-16.6%) | - | - |
| Dec 1999 | -$7.97M(+12.2%) | - | - |
| Dec 1998 | -$9.08M(-36.5%) | - | - |
| Dec 1997 | -$6.65M | - | - |
FAQ
- What is Arbutus Biopharma Corporation annual net profit?
- What is the all-time high annual net income for Arbutus Biopharma Corporation?
- What is Arbutus Biopharma Corporation annual net income year-on-year change?
- What is Arbutus Biopharma Corporation quarterly net profit?
- What is the all-time high quarterly net income for Arbutus Biopharma Corporation?
- What is Arbutus Biopharma Corporation quarterly net income year-on-year change?
- What is Arbutus Biopharma Corporation TTM net profit?
- What is the all-time high TTM net income for Arbutus Biopharma Corporation?
- What is Arbutus Biopharma Corporation TTM net income year-on-year change?
What is Arbutus Biopharma Corporation annual net profit?
The current annual net income of ABUS is -$69.92M
What is the all-time high annual net income for Arbutus Biopharma Corporation?
Arbutus Biopharma Corporation all-time high annual net profit is $29.80M
What is Arbutus Biopharma Corporation annual net income year-on-year change?
Over the past year, ABUS annual net profit has changed by +$2.93M (+4.02%)
What is Arbutus Biopharma Corporation quarterly net profit?
The current quarterly net income of ABUS is -$7.74M
What is the all-time high quarterly net income for Arbutus Biopharma Corporation?
Arbutus Biopharma Corporation all-time high quarterly net profit is $38.65M
What is Arbutus Biopharma Corporation quarterly net income year-on-year change?
Over the past year, ABUS quarterly net profit has changed by +$11.97M (+60.73%)
What is Arbutus Biopharma Corporation TTM net profit?
The current TTM net income of ABUS is -$42.28M
What is the all-time high TTM net income for Arbutus Biopharma Corporation?
Arbutus Biopharma Corporation all-time high TTM net profit is $30.70M
What is Arbutus Biopharma Corporation TTM net income year-on-year change?
Over the past year, ABUS TTM net profit has changed by +$34.42M (+44.88%)